Community investment: Shielding older adults from COVID-19 hospitalizations

COVID-19 is still sending older Canadians to hospital at high rates. Addressing their needs will benefit not only this population, but our entire community, says infectious disease expert Dawn Bowdish.

January 8, 2024

Image of a person holding onto a hospital bed

Expert Featured In This Story

Dawn Bowdish
Dawn Bowdish

Professor

See Profile

COVID-19 is still sending older Canadians to hospital at higher rates, and there’s more we can be doing to protect them, says infectious disease expert Dawn Bowdish.

Bowdish, the Canada Research Chair in Aging and Immunity, says taking these steps will not only benefit these older adults, but also our entire community.

“As we get older, the chance of returning to the life we once had if we are hospitalized for a serious infection like COVID becomes increasingly slim,” says Bowdish.

Life after a serious infection like COVID-19 can mean patients need more medical care, rehabilitation or even having to enter a long-term care home.

“This has major impacts on their lives and the lives of the people who care for them,” says Bowdish, who is a researcher with the Global Nexus School for Pandemic Prevention & Response.

Learn more in the video below about the three measures she says we could take that would help keep older adults out of hospital, and in turn, benefit our entire community.

Marek Smieja smiles while standing outside on a bright day.

McMaster scientist Marek Smieja receives prestigious national award for infectious disease research 

The John G. FitzGerald Award recognizes Smieja for advancing the diagnosis and epidemiology of respiratory and gastrointestinal infections, including those caused by SARS-CoV-2, influenza, rhinovirus, and C. difficile.
Toronto skyline enveloped in yellowish smog.

Everyday air pollution linked to poorer brain function, study finds

New research suggests that fine particles from traffic, industry and wildfire smoke are linked to worse cognitive function.
Smiling Sheila Singh wearing a McMaster lab coat, looking over lab equipment.

New McMaster-made drug candidate shows promise as a brain cancer treatment 

The drug candidate can eliminate deadly and aggressive glioblastoma tumours, which typically resist standard treatments and often recur rapidly.